چکیده (انگلیسی):

Background:Tailored feedback has been shown to be effective for modifying health risk behaviours and may aid
the provision of preventive care by general practitioners (GPs). However, provision of tailored patient feedback for
vulnerable or socially disadvantaged groups is not well explored. The aims of this study were to examine the
acceptability and effectiveness of providing generic compared to tailored feedback on self-reported health risk
behaviours among a high need sample of people attending an Aboriginal Community Controlled Health Service
(ACCHS).
Methods:Participants attending two ACCHSs in regional New South Wales completed a touch screen health risk
survey and received either generic or tailored health risk feedback. Participants were asked to complete an exit
survey after their appointment. The exit survey asked about feedback acceptability and effectiveness. Self-reported
ease of understanding, relevance and whether the generic versus tailored feedback helped patients talk to their GP
was compared using Chi-square analysis; The mean number of survey health risks talked about or for which
additional actions were undertaken (such as provision of lifestyle advice or referral) was compared usingt-tests.
Results:Eighty seven participants (36 % consent rate) completed the exit survey. Tailored feedback was rated as
more relevant and was more likely to be shown to the participant’s GP than generic feedback. There was no
difference in the mean number of health risk topics discussed or number of additional actions taken by the GP by
type of feedback.
Conclusions:Tailored and generic feedback showed no difference in effectiveness, and little difference in
acceptability, among this socially disadvantaged population. Completing a health risk survey and receiving any type
of feedback may have overwhelmed more subtle differences in outcomes between the generic and the tailored
feedback. Future work to rigorously evaluate the longer-term effectiveness of the provision of tailored health risk
feedback for Aboriginal Australians, as well as other high need groups, is still needed. Trial Registration: Australian
New Zealand Clinical Trials Registry ANZCTRN12614001205628. Registered 11 November 2014.